• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗2级高血压。

Treating stage 2 hypertension.

作者信息

Giles Thomas D, Materson Barry J

机构信息

University of Miami School of Medicine, Miami, FL 3310, USA.

出版信息

J Clin Hypertens (Greenwich). 2005 Aug;7(8):464-70. doi: 10.1111/j.1524-6175.2005.04535.x.

DOI:10.1111/j.1524-6175.2005.04535.x
PMID:16103757
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8109319/
Abstract

The prevalence of hypertension increases with advancing age, due primarily to increases in systolic blood pressure. Systolic hypertension is the most common form of hypertension in individuals over 50 years of age and reflects pathologic decreases in arterial compliance. Systolic blood pressure elevation is a more important risk factor for cardiovascular disease than is diastolic blood pressure elevation. Stage 2 hypertension, defined as blood pressure > or =160/100 mm Hg, is often found in older persons, who are at highest risk for cardiovascular events. In this clinical review, hypertension experts utilize a case study to provide a paradigm for treating older patients with stage 2 hypertension.

摘要

高血压的患病率随年龄增长而增加,主要原因是收缩压升高。收缩期高血压是50岁以上人群中最常见的高血压形式,反映了动脉顺应性的病理性降低。收缩压升高比舒张压升高是心血管疾病更重要的危险因素。2级高血压定义为血压≥160/100 mmHg,常见于老年人,他们发生心血管事件的风险最高。在本临床综述中,高血压专家利用一个病例研究为治疗老年2级高血压患者提供一个范例。

相似文献

1
Treating stage 2 hypertension.治疗2级高血压。
J Clin Hypertens (Greenwich). 2005 Aug;7(8):464-70. doi: 10.1111/j.1524-6175.2005.04535.x.
2
[Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].老年患者中难以控制的动脉高血压。“白大衣效应”的意义
Rev Port Cardiol. 1999 Oct;18(10):897-906.
3
Treating hypertension in the elderly: protagonist viewpoint.老年高血压的治疗:主角观点。
Am J Geriatr Cardiol. 2003 Nov-Dec;12(6):361-2. doi: 10.1111/j.1076-7460.2003.02915.x.
4
[Isolated systolic hypertension as risk factor. Also in this case lowering blood pressure makes sense].[单纯收缩期高血压作为危险因素。在这种情况下降低血压也是有意义的]
MMW Fortschr Med. 2000 Nov 23;142(47):26-8.
5
Isolated systolic hypertension: an important cardiovascular risk factor.单纯收缩期高血压:一种重要的心血管危险因素。
Blood Press. 1998 Jul;7(4):197-207. doi: 10.1080/080370598437222.
6
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.美国国家高血压预防、检测、评估与治疗联合委员会第七次报告:JNC 7报告。
JAMA. 2003 May 21;289(19):2560-72. doi: 10.1001/jama.289.19.2560. Epub 2003 May 14.
7
Systolic blood pressure: it's time to take control.收缩压:是时候加以控制了。
Am J Hypertens. 2004 Dec;17(12 Pt 2):49S-54S. doi: 10.1016/j.amjhyper.2004.08.020.
8
[Systolic hypertension-treat or not to treat?].[收缩期高血压——治疗还是不治疗?]
Herz. 2003 Dec;28(8):702-6. doi: 10.1007/s00059-003-2505-9.
9
Prevalence and implications of uncontrolled systolic hypertension.未控制的收缩期高血压的患病率及其影响
Drugs Aging. 2003;20(4):277-86. doi: 10.2165/00002512-200320040-00004.
10
Hypertension in older people: part 2.老年人高血压:第2部分。
J Clin Hypertens (Greenwich). 2006 Jul;8(7):521-5. doi: 10.1111/j.1524-6175.2006.05116.x.

引用本文的文献

1
The Association between Magnesium Depletion Score and Hypertension in US Adults: Evidence from the National Health and Nutrition Examination Survey (2007-2018).镁缺乏评分与美国成年人高血压的关联:来自全国健康和营养调查(2007-2018 年)的证据。
Biol Trace Elem Res. 2024 Oct;202(10):4418-4430. doi: 10.1007/s12011-023-04034-y. Epub 2023 Dec 26.
2
Advancement in the Cuffless and Noninvasive Measurement of Blood Pressure: A Review of the Literature and Open Challenges.无袖带无创血压测量的进展:文献综述与公开挑战
Bioengineering (Basel). 2022 Dec 24;10(1):27. doi: 10.3390/bioengineering10010027.
3
Blood Pressure Measurement: From Cuff-Based to Contactless Monitoring.血压测量:从基于袖带式到非接触式监测
Healthcare (Basel). 2022 Oct 21;10(10):2113. doi: 10.3390/healthcare10102113.
4
Advances in Cardiovascular Biomarker Discovery.心血管生物标志物发现的进展
Biomedicines. 2020 Nov 30;8(12):552. doi: 10.3390/biomedicines8120552.
5
The influence of locus control on adherence to treatment regimen among hypertensive patients.控制点对高血压患者治疗方案依从性的影响。
Patient Prefer Adherence. 2011 Apr 20;5:141-8. doi: 10.2147/PPA.S15098.

本文引用的文献

1
Diuretic-related side effects: development and treatment.利尿相关副作用:发生与治疗
J Clin Hypertens (Greenwich). 2004 Sep;6(9):532-40. doi: 10.1111/j.1524-6175.2004.03789.x.
2
The burden of adult hypertension in the United States 1999 to 2000: a rising tide.1999年至2000年美国成人高血压负担:呈上升趋势。
Hypertension. 2004 Oct;44(4):398-404. doi: 10.1161/01.HYP.0000142248.54761.56. Epub 2004 Aug 23.
3
Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.与钙通道阻滞剂单药治疗相比,初始血管紧张素转换酶抑制剂/钙通道阻滞剂联合治疗在2级高血压患者中能实现更好的血压控制。
Am J Hypertens. 2004 Jun;17(6):495-501. doi: 10.1016/j.amjhyper.2004.02.003.
4
Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.缓激肽在心力衰竭患者中对慢性血管紧张素转换酶抑制的全身血流动力学效应起作用。
Arterioscler Thromb Vasc Biol. 2004 Jun;24(6):1043-8. doi: 10.1161/01.ATV.0000129331.21092.1d. Epub 2004 Apr 22.
5
Adverse prognostic significance of new diabetes in treated hypertensive subjects.治疗的高血压患者新发糖尿病的不良预后意义。
Hypertension. 2004 May;43(5):963-9. doi: 10.1161/01.HYP.0000125726.92964.ab. Epub 2004 Mar 22.
6
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.全国高血压防治联合委员会第七次报告:预防、检测、评估及治疗
Hypertension. 2003 Dec;42(6):1206-52. doi: 10.1161/01.HYP.0000107251.49515.c2. Epub 2003 Dec 1.
7
Patient knowledge and awareness of hypertension is suboptimal: results from a large health maintenance organization.大型健康维护组织的调查结果显示,患者对高血压的认知和了解情况并不理想。
J Clin Hypertens (Greenwich). 2003 Jul-Aug;5(4):254-60. doi: 10.1111/j.1524-6175.2003.01963.x.
8
Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.1988 - 2000年美国高血压的患病率、知晓率、治疗率及控制率趋势
JAMA. 2003 Jul 9;290(2):199-206. doi: 10.1001/jama.290.2.199.
9
Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials.降压药物低剂量联合治疗的价值:354项随机试验分析
BMJ. 2003 Jun 28;326(7404):1427. doi: 10.1136/bmj.326.7404.1427.
10
Better blood pressure control: how to combine drugs.更好地控制血压:如何联合用药。
J Hum Hypertens. 2003 Feb;17(2):81-6. doi: 10.1038/sj.jhh.1001511.